Company Badge
USPTO Data Jan 1 1976 - Oct 20 2026
13 Patents
#565 in New York, NY
#1,377 in New York
#23,854 in US
#45,081 in the World
Remedy Pharmaceuticals, Inc.
Forward Citations = 41
5 inventors:
New York, NY, United States of America
Remedy Pharmaceuticals, Inc.
CIPO Patents = 2
EPO Patents = 3
Forward Citations = 41
Loading Chart...
Loading Chart...
5 inventors (with patents filed for the assignee):
Sven Jacobson (12 out of 42 patents)
Thomas W Macallister (5 out of 6 patents)
Yiqing Lin (1 out of 5 patents)
4. Deirdre Lowe (1 out of 2 patents)
5. Kenny K Tran (1 out of 1 patent)
6. Rupa Rishikesh Sawant (1 out of 1 patent)
7. Haihong Chen (1 out of 1 patent)
8. Martin Sven Jacobson (0 patent)
13 patents:
1. 12734182 - Methods of treating ischemic stroke at risk for cerebral or cerebellar edema (2026-09-15),
2. 12611416 - Methods of treating ischemic stroke at risk for cerebral or cerebellar edema (2026-04-28),
4. 12337006 - Methods of treating ischemic stroke at risk for cerebral or cerebellar edema (2025-06-24),
5. 12251389 - Methods of treating ischemic stroke at risk for cerebral or cerebellar edema (2025-03-18),
6. 12251388 - Methods of treating ischemic stroke at risk for cerebral or cerebellar edema (2025-03-18),
Company Overview
Remedy Pharmaceuticals, Inc. is a biopharmaceutical company based in New York, specializing in the development of innovative therapies for neurological and critical care conditions. The organization focuses on advancing treatments that address unmet medical needs, particularly in areas such as stroke and traumatic brain injury. With a commitment to scientific research and clinical development, Remedy Pharmaceuticals aims to improve patient outcomes through its proprietary drug candidates and therapeutic approaches.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Remedy Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/remedy-pharmaceuticals
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
2 patents (CIPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
3 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]